Investors who lost money on Supernus Pharmaceuticals, Inc. should contact Levi & Korsinsky about an ongoing investigation - SUPN
NEW YORK, NY / ACCESS Newswire / March 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Supernus ...
7,978 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Acquired by Atria Investments Inc
Atria Investments Inc bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund bought 7,978 shares of the specialty ...
Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Increased to Strong-Buy at StockNews.com
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a strong-buy rating in a report published on Sunday morning. Separately, Cantor Fitzgerald ...
Drug Store News4d
Dr. Reddy’s sells 14 generic non-strategic assets to Senores Pharma for U.S. expansion
The acquired portfolio consists of 13 ANDAs already approved by the Food and Drug Administration and one pending approval.
StockStory.org on MSN4d
Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
Kalkine Media6d
Is Supernus Pharmaceuticals (NASDAQ:SUPN) Seeing Increased Institutional Activity?
Highlights,Smartleaf Asset Management LLC increased its stake in Supernus Pharmaceuticals, reflecting growing institutional ...
Supernus Pharmaceuticals, Inc. (SUPN): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts
We recently compiled a list of the 10 Cash-Rich Small Cap Stocks To Invest In According To Analysts. In this article, we are ...
Morningstar14d
Supernus to Participate in Two Upcoming Investor Conferences
About Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS ...
Insider Monkey16d
Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now?
In this article, we are going to take a look at where Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) stands against the other small cap pharma stocks. Emily Field, Head of European Pharma Research ...
ADVFN18d
Form 4 - Statement of changes in beneficial ownership of securities
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. 2. These restricted stock units were settled in common stock upon vesting, which ...
Nasdaq19d
Supernus Pharmaceuticals CEO to Participate in Fireside Chat at TD Cowen Health Care Conference
Supernus Pharmaceuticals CEO will participate in a fireside chat at the TD Cowen Health Care Conference on March 3, 2025. Supernus Pharmaceuticals, Inc., a biopharmaceutical company specializing ...
manilatimes20d
Supernus to Participate in the TD Cowen 45th Annual Health Care Conference
ROCKVILLE, Md., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of ...